{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:15:35Z","timestamp":1790014535618,"version":"4.0.1"},"reference-count":51,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe University","doi-asserted-by":"publisher","award":["TTU-2021-19463"],"award-info":[{"award-number":["TTU-2021-19463"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Nonalcoholic fatty liver disease (NAFLD) is a metabolical disorder and can lead to liver fibrosis. Because it is commonly seen, several noninvasive scores (NS) have been validated to identify high-risk patients. Patients with NAFLD have been shown to have higher serum angiopoietin-like protein-8 (ANGPTL-8) levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The risk of NAFLD is known insufficiently in acromegaly. Moreover, the utility of the NS and the link between NAFLD and ANGPTL-8 in acromegaly is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-two patients with acromegaly (n = 15, active [AA] and n = 17, controlled acromegaly [CA]) and 19 healthy controls were included. Magnetic resonance imaging (MRI)-proton density fat fraction (PDFF) was used to evaluate hepatic steatosis, and magnetic resonance elastography to evaluate liver stiffness measurement. ANGPTL-8 levels were measured with ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median liver MRI-PDFF and NAFLD prevalence in AA were lower than in CA (P = .026 and P &amp;lt; .001, respectively). Median magnetic resonance elastography-liver stiffness measurement were similar across groups. Of the NS, visceral adiposity index, fatty liver index, hepatic steatosis index, and triglyceride-glucose index (TyG) all showed positive correlation with the liver MRI-PDFF in the control group. However, only TyG significantly correlated with liver fat in the AA and CA groups. There was no correlation between traditional NAFLD risk factors (body mass index, waist circumference, C-reactive protein, homeostasis model assessment for insulin resistance, visceral adipose tissue) and liver MRI-PDFF in the AA and CA. Patients with acromegaly with NAFLD had lower GH, IGF-1, and ANGPTL-8 levels than in those without NAFLD (P = .025, P = .011, and P = .036, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Active acromegaly may protect from NAFLD because of high GH. In patients with acromegaly, NAFLD risk cannot be explained with classical risk factors; hence, additional risk factors must be identified. TyG is the best score to evaluate NAFLD risk. Lower ANGPTL-8 in patients with acromegaly and NAFLD implies this hormone may be raised because of insulin resistance rather than being a cause for NAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad490","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:56:30Z","timestamp":1692276990000},"page":"e119-e129","source":"Crossref","is-referenced-by-count":25,"title":["Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Utility of Noninvasive Scores in Patients With Acromegaly"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6619-4141","authenticated-orcid":false,"given":"\u0130mdat","family":"Ero\u011flu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hacettepe University, School of Medicine , 06230, Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8133-0313","authenticated-orcid":false,"given":"Burcin Gonul","family":"Iremli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hacettepe University, School of Medicine , 06230, Ankara , Turkey"},{"name":"Department of Endocrinology and Metabolism, Hacettepe University, School of Medicine , 06230, Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1913-2404","authenticated-orcid":false,"given":"Ilkay S","family":"Idilman","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hacettepe University, School of Medicine , 06230, Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-5447","authenticated-orcid":false,"given":"Deniz","family":"Yuce","sequence":"additional","affiliation":[{"name":"Department of Preventive Oncology, Hacettepe University, School of Medicine , 06230, Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-5746","authenticated-orcid":false,"given":"Incilay","family":"Lay","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hacettepe University, School of Medicine , 06230, Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1318-0085","authenticated-orcid":false,"given":"Deniz","family":"Akata","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hacettepe University, School of Medicine , 06230, Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1377-9394","authenticated-orcid":false,"given":"Tomris","family":"Erbas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hacettepe University, School of Medicine , 06230, Ankara , Turkey"},{"name":"Department of Endocrinology and Metabolism, Hacettepe University, School of Medicine , 06230, Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"issue":"3","key":"2023122122195867700_dgad490-B1","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/EJE-20-0065","article-title":"Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease","volume":"183","author":"Ruissen","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"39","key":"2023122122195867700_dgad490-B2","doi-asserted-by":"crossref","first-page":"11053","DOI":"10.3748\/wjg.v21.i39.11053","article-title":"Endocrine causes of nonalcoholic fatty liver disease","volume":"21","author":"Marino","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"5","key":"2023122122195867700_dgad490-B3","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134638","article-title":"Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly","volume":"5","author":"Fellinger","year":"2020","journal-title":"JCI Insight"},{"issue":"11","key":"2023122122195867700_dgad490-B4","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2014-2242","article-title":"No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy","volume":"99","author":"Winhofer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023122122195867700_dgad490-B5","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1210\/jc.2017-01210","article-title":"Body composition and ectopic lipid changes with biochemical control of acromegaly","volume":"102","author":"Bredella","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023122122195867700_dgad490-B6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/ejendo\/lvac014","article-title":"Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment","volume":"188","author":"Arlien-S\u00f8borg","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2023122122195867700_dgad490-B7","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/jc.2015-1917","article-title":"Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment","volume":"100","author":"Reyes-Vidal","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023122122195867700_dgad490-B8","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad028","article-title":"Long-term outcome of body composition, ectopic lipid, and insulin resistance changes with surgical treatment of acromegaly","volume":"7","author":"Kuker","year":"2023","journal-title":"J Endocr Soc"},{"key":"2023122122195867700_dgad490-B9","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5421961","article-title":"Hepatic Steatosis Index in acromegaly: correlation with insulin resistance regardless of the disease control","volume":"2018","author":"Ciresi","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2023122122195867700_dgad490-B10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.933039","article-title":"The acromegaly lipodystrophy","volume":"13","author":"Freda","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2023122122195867700_dgad490-B11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","article-title":"MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice","volume":"65","author":"Dulai","year":"2016","journal-title":"J Hepatol"},{"issue":"10","key":"2023122122195867700_dgad490-B12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2023122122195867700_dgad490-B13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"2023122122195867700_dgad490-B14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"12","key":"2023122122195867700_dgad490-B15","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/liv.13941","article-title":"Visceral adiposity index as a predictor of NAFLD: a prospective study with 4-year follow-up","volume":"38","author":"Xu","year":"2018","journal-title":"Liver Int"},{"issue":"1","key":"2023122122195867700_dgad490-B16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","article-title":"The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease","volume":"16","author":"Zhang","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"2","key":"2023122122195867700_dgad490-B17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MEG.0000000000000255","article-title":"Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"27","author":"Subasi","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"2023122122195867700_dgad490-B18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.14218\/JCTH.2021.00311","article-title":"Validation of non-invasive fibrosis scores for predicting advanced fibrosis in metabolic-associated fatty liver disease","volume":"10","author":"Chen","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"2023122122195867700_dgad490-B19","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/jdi.12792","article-title":"Angiopoietin-like protein 8\/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non-alcoholic fatty liver disease patients","volume":"9","author":"Hong","year":"2018","journal-title":"J Diabetes Investig"},{"issue":"1","key":"2023122122195867700_dgad490-B20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-021-01481-1","article-title":"Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis","volume":"20","author":"Ke","year":"2021","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2023122122195867700_dgad490-B21","doi-asserted-by":"crossref","first-page":"24013","DOI":"10.1038\/srep24013","article-title":"Association between betatrophin\/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"2023122122195867700_dgad490-B22","doi-asserted-by":"crossref","first-page":"101394","DOI":"10.1016\/j.ghir.2021.101394","article-title":"Prevalence and predictors of abnormal glucose tolerance and its resolution in acromegaly: single centre retrospective study of 90 cases","volume":"59","author":"Khaire","year":"2021","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"2023122122195867700_dgad490-B23","first-page":"e13852","article-title":"Patterns of abnormal glucose metabolism in acromegaly and impact of treatment modalities on glucose metabolism","volume":"13","author":"Khan","year":"2021","journal-title":"Cureus"},{"issue":"7","key":"2023122122195867700_dgad490-B24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2023122122195867700_dgad490-B25","first-page":"109","article-title":"Nonalcoholic fatty liver disease, Liver fibrosis, and utility of noninvasive scores in patients with acromegaly","author":"Ero\u011flu","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2023122122195867700_dgad490-B26","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/730827","article-title":"Visceral adiposity index: an indicator of adipose tissue dysfunction","volume":"2014","author":"Amato","year":"2014","journal-title":"Int J Endocrinol"},{"issue":"4","key":"2023122122195867700_dgad490-B27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"2023122122195867700_dgad490-B28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"issue":"10","key":"2023122122195867700_dgad490-B29","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","article-title":"Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease","volume":"57","author":"Harrison","year":"2008","journal-title":"Gut"},{"issue":"6","key":"2023122122195867700_dgad490-B30","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"2023122122195867700_dgad490-B31","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1148\/radiol.2017161228","article-title":"Prevalence of fatty liver disease and hepatic iron overload in a northeastern German population by using quantitative MR imaging","volume":"284","author":"K\u00fchn","year":"2017","journal-title":"Radiology"},{"key":"2023122122195867700_dgad490-B32","author":"Swinscow","year":"2002"},{"issue":"2","key":"2023122122195867700_dgad490-B33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocr Rev"},{"issue":"8 Pt 1","key":"2023122122195867700_dgad490-B34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/diab.31.8.663","article-title":"Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization","volume":"31","author":"Rizza","year":"1982","journal-title":"Diabetes"},{"issue":"4","key":"2023122122195867700_dgad490-B35","doi-asserted-by":"crossref","first-page":"e00090","DOI":"10.1002\/edm2.90","article-title":"Hepatic steatosis in patients with acromegaly","volume":"2","author":"Koutsou-Tassopoulou","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"issue":"4","key":"2023122122195867700_dgad490-B36","doi-asserted-by":"crossref","first-page":"e33308","DOI":"10.1371\/journal.pone.0033308","article-title":"Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin","volume":"7","author":"Shah","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"2023122122195867700_dgad490-B37","doi-asserted-by":"crossref","first-page":"15273","DOI":"10.1038\/s41598-018-33419-6","article-title":"Association between body mass index and fatty liver risk: a dose-response analysis","volume":"8","author":"Fan","year":"2018","journal-title":"Sci Rep"},{"key":"2023122122195867700_dgad490-B38","doi-asserted-by":"crossref","first-page":"540398","DOI":"10.1155\/2012\/540398","article-title":"Clinical manifestations and diagnosis of acromegaly","volume":"2012","author":"Lugo","year":"2012","journal-title":"Int J Endocrinol"},{"issue":"4","key":"2023122122195867700_dgad490-B39","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1210\/jc.2011-2681","article-title":"Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial","volume":"97","author":"Madsen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023122122195867700_dgad490-B40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-12-0252","article-title":"Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy","volume":"167","author":"Nishizawa","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023122122195867700_dgad490-B41","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/gut.52.6.914","article-title":"Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency","volume":"52","author":"Ichikawa","year":"2003","journal-title":"Gut"},{"issue":"9","key":"2023122122195867700_dgad490-B42","doi-asserted-by":"crossref","first-page":"e3624","DOI":"10.1210\/clinem\/dgac405","article-title":"The GH\/IGF-1 axis is associated with intrahepatic lipid content and hepatocellular damage in overweight\/obesity","volume":"107","author":"Dichtel","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023122122195867700_dgad490-B43","doi-asserted-by":"crossref","first-page":"e44136","DOI":"10.1371\/journal.pone.0044136","article-title":"Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"issue":"Supplement_1","key":"2023122122195867700_dgad490-B44","doi-asserted-by":"crossref","first-page":"A525-A","DOI":"10.1210\/jendso\/bvac150.1093","article-title":"OR27-2 growth hormone reduces hepatic steatosis, inflammation and fibrosis in adults with overweight\/obesity and nonalcoholic fatty liver disease","volume":"6","author":"Bartsch","year":"2022","journal-title":"J Endocr Soc"},{"issue":"1","key":"2023122122195867700_dgad490-B45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12902-022-00967-y","article-title":"Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease","volume":"22","author":"Xue","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"2023122122195867700_dgad490-B46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41574-022-00702-6","article-title":"Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer","volume":"18","author":"Kopchick","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2023122122195867700_dgad490-B47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12944-018-0802-9","article-title":"Association between circulating full-length angiopoietin-like protein 8 and non-high-density lipoprotein cholesterol levels in Chinese non-diabetic individuals: a cross-sectional study","volume":"17","author":"Yang","year":"2018","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2023122122195867700_dgad490-B48","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1038\/srep05013","article-title":"Elevated circulating lipasin\/betatrophin in human type 2 diabetes and obesity","volume":"4","author":"Fu","year":"2014","journal-title":"Sci Rep"},{"issue":"12","key":"2023122122195867700_dgad490-B49","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1507\/endocrj.EJ19-0263","article-title":"Regulation of angiopoietin-like protein 8 expression under different nutritional and metabolic status","volume":"66","author":"Guo","year":"2019","journal-title":"Endocr J"},{"issue":"7","key":"2023122122195867700_dgad490-B50","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s40618-020-01444-w","article-title":"Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi syndrome","volume":"44","author":"Mele","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"2023122122195867700_dgad490-B51","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210106","article-title":"Angptl8 in metabolic homeostasis: more friend than foe?","volume":"11","author":"Guo","year":"2021","journal-title":"Open Biol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad490\/51966543\/dgad490.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/1\/e119\/54731523\/dgad490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/1\/e119\/54731523\/dgad490.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T17:21:30Z","timestamp":1703179290000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/1\/e119\/7244424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,17]]},"published-print":{"date-parts":[[2023,12,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad490","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,8,17]]}}}